Two-year experience with the german-translated version of the NIH-CPSI in patients with CP/CPPS

Schneider, H.; Brähler, Elmar; Ludwig, Martin; Hochreiter, Werner W.; Collins, Mary F. McNaughton; Eremenco, Sonya; Weidner, W.

doi:10.1016/j.urology.2004.02.002

Cited by 32 publications

(22 citation statements)

References 24 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Krieger et al [14] demonstrated an increased severity and frequency of symptoms in men with inflammatory CP/CPPS; whereas Schneider et al [15] found that NIH category IIIB non-inflammatory patients are significantly more symptomatic than category IIIA patients.…”

Section: Symptom Scoring Questionnairesmentioning

confidence: 99%

Evaluation of acute and chronic bacterial prostatitis and diagnostic management of chronic prostatitis/chronic pelvic pain syndrome with special reference to infection/inflammation

Weidner

Anderson

2008

International Journal of Antimicrobial Agents

View full text Add to dashboard Cite

Section: Symptom Scoring Questionnairesmentioning

confidence: 99%

Evaluation of acute and chronic bacterial prostatitis and diagnostic management of chronic prostatitis/chronic pelvic pain syndrome with special reference to infection/inflammation

Weidner

Anderson

2008

International Journal of Antimicrobial Agents

View full text Add to dashboard Cite

“…It is desirable to incorporate a validated survey instrument such as the National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI) [3]. To facilitate evaluation of varied populations, the NIH-CPSI has been translated and validated for use in English [3], Spanish [4], Japanese [5], Chinese [6], Malay [6], German [7], Korean [8], Finnish [9], Italian [10], French [11], and Estonian [12]. However, a population-based study found low agreement between physician-diagnosed prostatitis and the NIH-CPSI pain measures, suggesting that the index, by itself, may have limited ability to determine the presence or absence of prostatitis [13].…”

Section: Inclusion Criteria For Epidemiological Studiesmentioning

confidence: 99%

Epidemiology of prostatitis

Krieger

Lee

Jeon

et al. 2008

International Journal of Antimicrobial Agents

309

158

View full text Add to dashboard Cite

Background-Prostatitis describes a combination of infectious diseases (acute and chronic bacterial prostatitis), chronic pelvic pain syndrome, and asymptomatic inflammation.Materials and methods-We employed evidence-based methods to review the epidemiology of prostatitis syndromes.Results-The prevalence of prostatitis symptoms could be compared in five studies surveying 10 617 men. Overall, 873 participants met various criteria for prostatitis, representing an overall rate of 8.2%, with prevalence ranging from 2.2 to 9.7%. A history of sexually transmitted diseases was associated with an increased risk for prostatitis symptoms. Men reporting a history of prostatitis symptoms had a substantially increased rate of benign prostatic hyperplasia, lower urinary tract symptoms and prostate cancer. In one study, the incidence of physician-diagnosed prostatitis was 4.9 cases per 1000 person-years. Two studies suggest that about one-third of men reporting prostatitis symptoms had resolution after 1 year. Patients with previous episodes and more severe symptoms are at higher risk for chronic pelvic pain.Discussion-The prevalence of prostatitis symptoms is high, comparable to rates of ischamic heart disease and diabetes. Clinical evaluation appears necessary to verify that prostatitis is responsible for patients' symptoms. Prostatitis symptoms may increase a man's risk for benign prostate hypertrophy, lower urinary tract symptoms and prostate cancer. We need to define natural history and consequences of prostatitis, develop better algorithms for diagnosis and treatment, and develop strategies for prevention.A resurgence of interest in prostatitis has occurred during the last decade. This has been accompanied by a new level of understanding of the epidemiology, morbidity and economic impact of these conditions. Much progress dates from the recognition that infection and inflammation are important in certain prostatitis syndromes. Despite limited information on the causes of other prostatitis syndromes, these conditions can be defined and important treatment studies have been initiated. This article employs evidence-based methods to review the epidemiology of prostatitis syndromes, examines the clinical implications of these data, and outlines areas for future research.

show abstract

“…Evaluation of patients with CBP included (17): the NIH chronic prostatitis symptom index German version (18), physical examination including digital rectal examination of the prostate, transrectal ultrasound (TRUS), the 4-glass test with search for common urinary bacteria, mycoplasma and yeasts in all urine fractions (first voided urine: VB1, midstream urine: VB2, and post-prostatic massage urine: VB3) and expressed prostatic secretions (EPS), ejaculate analysis (19), polymerase chain reaction (PCR) for Chlamydia (C.) trachomatis in VB1 (Abbott, Wiesbaden, Germany), and microscopic examination of VB3 for detection of Trichomonas vaginalis (20).…”

Section: Categorization Of Cbp Chronic Epididymitis and Chronic Uretmentioning

confidence: 99%

Impact of infection on the secretory capacity of the male accessory glands

et al. 2009

View full text Add to dashboard Cite

show abstract

Two-year experience with the german-translated version of the NIH-CPSI in patients with CP/CPPS

Cited by 32 publications

References 24 publications

Evaluation of acute and chronic bacterial prostatitis and diagnostic management of chronic prostatitis/chronic pelvic pain syndrome with special reference to infection/inflammation

Evaluation of acute and chronic bacterial prostatitis and diagnostic management of chronic prostatitis/chronic pelvic pain syndrome with special reference to infection/inflammation

Epidemiology of prostatitis

Impact of infection on the secretory capacity of the male accessory glands

Contact Info

Product

Resources

About